Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,220,183
+$8,303,141 QoQ
Shares Held
202,455
+200.6% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#79
of 314 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. XENE ranks #12 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 6 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 | |
| 8 | EXEL |
Exelixis, Inc.
|
275,209 | $14,974,121 |
All Filings in XENE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,220,183 | 202,455 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,917,042 | 67,361 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $446,762 | 11,397 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $665,628 | 16,907 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,592,624 | 40,847 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,017,925 | 46,874 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $286,671 | 7,446 | Shares | Sole | 2023-08-11 | |
| 2021-09-30 | $354,694 | 23,213 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $360,532 | 31,793 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||